Literature DB >> 24475431

Antiphospholipid syndrome: A disease of protean face.

Mohammadreza Ardalan1, Amir Vahedi2.   

Abstract

BACKGROUND: Antiphospholipid syndrome (APS) is a systemic disorder characterizes by recurrent arterial and venous thrombosis and/or pregnancy miscarriages and positive test for antiphospholipid antibodies. CASE: Here we report a 31 year-old female whose main complain was symmetrical motor polyneuropathy and hand muscular weakness over a long period of time. Her clinical picture became more complex by Mitral valve regurgitation and renal dysfunction. Finally with the diagnosis of APS glucocorticoid therapy was started and her renal dysfunction improved profoundly, however her cardiac valvular involvement and peripheral neuropathy remained.
CONCLUSIONS: APS is a disease with wide clinical presentations and it continues to confound the clinicians.

Entities:  

Keywords:  Antiphospholipid antibody syndrome; Motor polyneuropathy; Nephropathy; Venous thrombosis

Year:  2013        PMID: 24475431      PMCID: PMC3886183          DOI: 10.5812/nephropathol.9001

Source DB:  PubMed          Journal:  J Nephropathol        ISSN: 2251-8363


  11 in total

Review 1.  What nephrologists need to know about antiphospholipid syndrome.

Authors:  Bassam Alchi; Meryl Griffiths; David Jayne
Journal:  Nephrol Dial Transplant       Date:  2010-06-28       Impact factor: 5.992

Review 2.  Revisiting beta 2 glycoprotein I, the major autoantigen in the antiphospholipid syndrome.

Authors:  Soheila Rahgozar
Journal:  Iran J Immunol       Date:  2012-06       Impact factor: 1.603

Review 3.  Kidney disease in antiphospholipid syndrome.

Authors:  Mary-Carmen Amigo
Journal:  Rheum Dis Clin North Am       Date:  2006-08       Impact factor: 2.670

Review 4.  Cardiac manifestations in the antiphospholipid syndrome.

Authors:  Felicia Tenedios; Doruk Erkan; Michael D Lockshin
Journal:  Rheum Dis Clin North Am       Date:  2006-08       Impact factor: 2.670

5.  Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography.

Authors:  M Turiel; S Muzzupappa; B Gottardi; C Crema; P Sarzi-Puttini; E Rossi
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  Peripheral neuropathy in patients with primary antiphospholipid (Hughes') syndrome.

Authors:  M S F Santos; J F de Carvalho; M Brotto; E Bonfa; F A C Rocha
Journal:  Lupus       Date:  2010-02-15       Impact factor: 2.911

Review 7.  Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome.

Authors:  G R V Hughes
Journal:  Postgrad Med J       Date:  2003-02       Impact factor: 2.401

Review 8.  Antiphospholipid antibodies and renal involvement.

Authors:  Antonietta Gigante; Maria Ludovica Gasperini; Rosario Cianci; Biagio Barbano; Konstantinos Giannakakis; Domenico Di Donato; Giorgio Fuiano; Antonio Amoroso
Journal:  Am J Nephrol       Date:  2009-08-28       Impact factor: 3.754

Review 9.  The role of complement in the antiphospholipid syndrome.

Authors:  Jane E Salmon; Guillermina Girardi
Journal:  Curr Dir Autoimmun       Date:  2004

10.  The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.

Authors:  R Cervera; M-C Boffa; M A Khamashta; G R V Hughes
Journal:  Lupus       Date:  2009-09       Impact factor: 2.911

View more
  3 in total

1.  Antiphospholipid Syndrome: A complex disease.

Authors:  Fátima Serrano
Journal:  J Nephropathol       Date:  2013-01-01

2.  Antiphospholipid antibodies and systemic scleroderma.

Authors:  Muhammed Mubarak; Hamid Nasri
Journal:  Turk J Haematol       Date:  2013-12-05       Impact factor: 1.831

Review 3.  Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidants.

Authors:  Azar Baradaran; Hamid Nasri; Mahmoud Rafieian-Kopaei
Journal:  J Res Med Sci       Date:  2014-04       Impact factor: 1.852

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.